La prescription médicale. Presses universitaires Aix-Marseille, pp.63-79, 1998. ,
Prescriptions m??dicamenteuses en g??riatrie??: overuse (sur-utilisation), misuse (mauvaise utilisation), underuse (sous-utilisation). Analyse qualitative ?? partir des ordonnances de 200??patients entrant dans un service de court s??jour g??riatrique, La Revue de M??decine Interne, vol.33, issue.3, pp.122-129, 2012. ,
DOI : 10.1016/j.revmed.2011.11.016
Appropriate prescribing in elderly people: how well can it be measured and optimised?, The Lancet, vol.370, issue.9582, pp.173-84, 2007. ,
DOI : 10.1016/S0140-6736(07)61091-5
Inappropriate prescribing in the older population: need for new criteria, Age and Ageing, vol.37, issue.2, pp.138-179, 2008. ,
DOI : 10.1093/ageing/afm189
STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people], Can J Public Health, vol.100, issue.6, pp.426-457, 2009. ,
Drug therapy. Lancet, Jul, vol.1346, issue.8966, pp.32-38, 1995. ,
Clinical consequences of polypharmacy in elderly, Expert Opinion on Drug Safety, vol.5, issue.1, pp.57-65 ,
DOI : 10.2165/00003495-200969040-00001
A new version of the STOPP-START criteria, a new step towards improving drug prescription in older patients. European Geriatric Medicine, pp.363-367, 2014. ,
Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Archives of Internal Medicine, pp.1825-1857, 1991. ,
Defining inappropriate practices in prescribing for elderly people: a national consensus panel, CMAJ. Feb, vol.1156, issue.3, pp.385-91, 1997. ,
Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) ,
Assessing Care of Vulnerable Elders: Methods for Developing Quality Indicators, Annals of Internal Medicine, vol.135, issue.8_Part_2, pp.647-52, 2001. ,
DOI : 10.7326/0003-4819-135-8_Part_2-200110161-00003
Potentially inappropriate medications in the elderly: a French consensus panel list, European Journal of Clinical Pharmacology, vol.23, issue.8, pp.725-756, 2007. ,
DOI : 10.1007/s00228-007-0324-2
Inappropriate Drug Prescription at Nursing Home Admission, Journal of the American Medical Directors Association, vol.13, issue.1, pp.83-92 ,
DOI : 10.1016/j.jamda.2011.02.009
Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia, The American Journal of Geriatric Pharmacotherapy, vol.3, issue.4, pp.246-54, 2005. ,
DOI : 10.1016/j.amjopharm.2005.12.007
Potentially Inappropriate Drug Prescribing and Associated Factors in Nursing Homes, Journal of the American Medical Directors Association, vol.15, issue.11, pp.850-851, 2014. ,
DOI : 10.1016/j.jamda.2014.08.003
Potentially Inappropriate Drug Prescriptions and Risk of Hospitalization among Older, Italian, Nursing Home Residents, Drugs & Aging, vol.286, issue.4, pp.747-58, 2010. ,
DOI : 10.2165/11538240-000000000-00000
Frequency and risk factors of potentially inappropriate medication use in a communitydwelling elderly population: results from the 3C Study, Eur J Clin Pharmacol, 2005. ,
Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing, European Journal of Internal Medicine, vol.25, issue.8, pp.710-716, 2014. ,
DOI : 10.1016/j.ejim.2014.07.011
Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.67, issue.6, 2012. ,
DOI : 10.1093/gerona/glr233
Prevalence and Associations of the Use of Proton-Pump Inhibitors in Nursing Homes: A Cross-Sectional Study, Journal of the American Medical Directors Association, 2013. ,
Inappropriate Prescribing of Proton Pump Inhibitors in Older Patients, Drugs & Aging, vol.33, issue.12, pp.681-90, 2012. ,
DOI : 10.1007/BF03262283
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly, European Journal of Internal Medicine, vol.22, issue.2, pp.205-215, 2011. ,
DOI : 10.1016/j.ejim.2010.11.009
Appropriate proton pump inhibitor use among older adults: A retrospective chart review, The American Journal of Geriatric Pharmacotherapy, vol.6, issue.5, pp.249-254, 2008. ,
Top 20 Global Therapeutic Classes Total Audited Markets. [internet]. [accès le 27, Disponible sur, 2010. ,
Top 15 Global ProductsTotal Audited Markets. [internet]. [accès le 28, Disponible sur, 2009. ,
Disponible sur : http://www.has-sante, 2009. ,
Dépense de santé 2013 : Lucentis, Humira, Crestor en tête des remboursements. [internet]. [accès le 28, Disponible sur, p.3600572 ,
Analyse des ventes de médicaments en France en 2013, 2014. ,
HAS ? Haute Autorité de Santé Médicaments inhibiteurs de la pompe à protons chez l'adulte : réévaluation. Paris [internet]. [accès le 10 Disponible sur : http://www.has-sante.fr/portail NICE -National Institute for Clinical Excellence. Dyspepsia and gastro?oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro?oesophageal reflux disease, or both. Clinical guideline (update, 27_14-15-18_458.pdf 31 Disponible sur, 2009. ,
Review article: the clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology and Therapeutics, pp.2-8, 2006. ,
Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies, The American Journal of Medicine, vol.124, issue.6, pp.519-545, 2011. ,
DOI : 10.1016/j.amjmed.2011.01.007
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-53, 2006. ,
DOI : 10.1001/jama.296.24.2947
S1225 Proton Pump Inhibitors Increase Risk of Severe Disease Among Patients Hospitalized With Clostridium difficile Associated Diarrhea, Gastroenterology, vol.138, issue.5, p.208, 2010. ,
DOI : 10.1016/S0016-5085(10)60941-9
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection, Archives of Internal Medicine, vol.170, issue.9, pp.784-90, 2010. ,
DOI : 10.1001/archinternmed.2010.89
Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies, Renal Failure, vol.29, issue.7, pp.1237-1278, 2015. ,
DOI : 10.1038/ki.2012.462
Safety of Proton Pump Inhibitor Exposure, Gastroenterology, vol.139, issue.4, 2010. ,
DOI : 10.1053/j.gastro.2010.08.023
Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy, Alimentary Pharmacology and Therapeutics, vol.183, issue.1, pp.83-98, 1998. ,
DOI : 10.1001/archinte.117.5.667
Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis, Expert Review of Clinical Pharmacology, vol.5, issue.3, pp.337-381 ,
DOI : 10.1586/ecp.12.20
Risk of Community-Acquired Pneumonia and Use of Gastric Acid???Suppressive Drugs, JAMA, vol.292, issue.16, 2004. ,
DOI : 10.1001/jama.292.16.1955
Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals, JAMA Internal Medicine, vol.173, issue.7, pp.518-541, 2013. ,
DOI : 10.1001/jamainternmed.2013.2851
Risk of Death Associated With Use of PPIs in Three Cohorts of Institutionalized Older People in Finland, Journal of the American Medical Directors Association, vol.13, issue.5, pp.488-497 ,
DOI : 10.1016/j.jamda.2012.03.003
Clopidogrel with or without Omeprazole in Coronary Artery Disease, New England Journal of Medicine, vol.363, issue.20, pp.1909-1926, 2010. ,
DOI : 10.1056/NEJMoa1007964
No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Meta-analysis, International Journal of Cardiology, vol.167, issue.3, pp.965-74, 2013. ,
DOI : 10.1016/j.ijcard.2012.03.085
Bon usage des agents antiplaquettaires, Disponible sur, 2012. ,
Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs) ,
Inhibiteurs de la pompe à protons : risque de fractures osseuses -4 avril 2013. [internet]. [accès le 10, Disponible sur, 2015. ,
Possible Increased Risk of Bone Fractures With Certain Antacid Drugs, Disponible sur : http://www.fda.gov/Drugs/DrugSafety, 2010. ,
Prescription médicamenteuse du sujet âgé. EMC -Médecine, 2005. ,
expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, vol.52, issue.18, pp.1502-1519, 2008. ,
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis, PLOS ONE, vol.16, issue.7, p.131558, 2015. ,
DOI : 10.1371/journal.pone.0131558.s003
??tude Polychrome??: Une m??thode d'expertise pour optimiser des ordonnances de polyprescription en m??decine g??n??rale, Pratiques et Organisation des Soins, vol.40, issue.3, pp.167-175, 2009. ,
DOI : 10.3917/pos.403.0167
Rapport sur l'utilisation des inhibiteurs de la pompe à protons : les recommandations françaises sont-elles respectées ? La Revue de Médecine Interne, pp.651-658, 2015. ,
DOI : 10.1016/j.revmed.2015.04.014
Upper Gastrointestinal Bleeding in Patients with Aspirin and Clopidogrel Co-Therapy, Digestion, vol.77, issue.3-4, pp.3-4173, 2008. ,
DOI : 10.1159/000141264
Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: Facts or fancies?, European Journal of Internal Medicine, vol.21, issue.6, pp.484-493, 2010. ,
DOI : 10.1016/j.ejim.2010.08.004
Public-health advisory: Updated safety information about a drug interaction between clopidogrel bisulfate and omeprazole, www.fda.gov/Drugs, 2009. ,
Public statement on possible interaction between clopidogrel and proton pump inhibitors, pp.194-194, 2009. ,
Disponible sur : http://www.ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux- professionnels-de-sante/Interaction-entre-clopidogrel-et-les-inhibiteurs-de-la-pompe-a- protons-IPP-Lettre-aux-professionnels-de-sante, 2009. ,
Etude d'usage des médicaments en EHPAD entre 2011 et 2013, Rev Geriatr, vol.40, issue.4, pp.209-233, 2015. ,
A multicentric individually-tailored controlled trial of education and professional support to nursing home staff: Research protocol and baseline data of the IQUARE study, The journal of nutrition, health & aging, vol.50, issue.4, pp.173-181, 2013. ,
DOI : 10.1007/s12603-013-0008-9
URL : https://hal.archives-ouvertes.fr/halshs-00847527
Analgesic consumption in nursing homes: observational study about 99 nursing homes, 1089. ,
Polypharmacy in the elderly: A literature review, Journal of the American Academy of Nurse Practitioners, vol.66, issue.10, pp.123-155, 2005. ,
DOI : 10.1093/fampra/17.3.261
Exploring Variation in Rates of Polypharmacy Across Long Term Care Homes, Journal of the American Medical Directors Association, vol.13, issue.3, 2012. ,
DOI : 10.1016/j.jamda.2011.07.001
Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey, The American Journal of Geriatric Pharmacotherapy, vol.8, issue.1, pp.63-72, 2010. ,
DOI : 10.1016/j.amjopharm.2010.01.001
Consommation Médicamenteuse chez le Sujet Agé. Consommation, Prescription, Iatrogénie et Observance, Disponible sur, 2005. ,
Polypharmacy in elderly patients, The American Journal of Geriatric Pharmacotherapy, vol.5, issue.4, pp.345-51, 2007. ,
DOI : 10.1016/j.amjopharm.2007.12.002
Polypharmacy Status as an Indicator of Mortality in an Elderly Population, Drugs & Aging, vol.57, issue.12, pp.1039-1087, 2009. ,
DOI : 10.2165/11319530-000000000-00000
Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans, Journal of the American Geriatrics Society, vol.57, issue.1, pp.34-41 ,
DOI : 10.1111/j.1532-5415.2011.03772.x
Risk Factors for Adverse Drug Events Among Nursing Home Residents, Archives of Internal Medicine, vol.161, issue.13, pp.1629-1663, 2001. ,
DOI : 10.1001/archinte.161.13.1629
Factors associated with falls among older adults living in institutions, BMC Geriatrics, vol.158, issue.1, p.6, 2013. ,
DOI : 10.1093/aje/kwg203
Ministère des affaires sociales et de la Santé. La politique du médicament en EHPAD, 2013. ,
Rates, variability, and associated factors of polypharmacy in nursing home patients, Clinical Interventions in Aging, vol.8, pp.1585-90, 2013. ,
DOI : 10.2147/CIA.S52698
Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics, Pharmacoepidemiology and Drug Safety, vol.163, issue.22, pp.1041-1049, 2010. ,
DOI : 10.1002/pds.1983
Healthcare Outcomes Associated with Beers' Criteria: A Systematic Review, Annals of Pharmacotherapy, vol.41, issue.3, pp.438-485, 2007. ,
DOI : 10.1345/aph.1H473
Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents, Archives of Internal Medicine, vol.165, issue.1, pp.68-74, 2005. ,
DOI : 10.1001/archinte.165.1.68
Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents. Scand J Prim Health Care, pp.154-163, 2010. ,
Use of Proton Pump Inhibitors and Other Acid Suppressive Medications in Newly Admitted Nursing Facility Patients, Journal of the American Medical Directors Association, vol.8, issue.9, 2007. ,
DOI : 10.1016/j.jamda.2007.07.001
Daily Medication Use in Nursing Home Residents with Advanced Dementia, Journal of the American Geriatrics Society, vol.63, issue.5, pp.880-888, 2010. ,
DOI : 10.1111/j.1532-5415.2010.02819.x
497 Prevalence and Predictors of Non-Evidence Based Proton Pump Inhibitor Use Among Elderly Nursing Home Residents in the USA, Gastroenterology, vol.148, issue.4, p.95 ,
DOI : 10.1016/S0016-5085(15)30329-2
Use of proton pump inhibitors and mortality among institutionalized older people, Arch Intern Med, vol.170, issue.17, pp.1604-1609, 2010. ,
Patterns of proton pump inhibitor use in clinical practice, The American Journal of Medicine, vol.111, issue.6, pp.469-73, 2001. ,
DOI : 10.1016/S0002-9343(01)00901-9
Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration, Alimentary Pharmacology & Therapeutics, vol.98, issue.Suppl. 146, pp.103-114, 1992. ,
DOI : 10.1111/j.1365-2036.1992.tb00550.x
Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors, The American Journal of Gastroenterology, vol.89, issue.108, pp.763-770, 1998. ,
DOI : 10.1046/j.1365-2036.1996.33175000.x
Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial, The American Journal of Gastroenterology, vol.62, issue.9, pp.1914-1936, 2005. ,
DOI : 10.1046/j.1524-4733.2002.52101.x
Potentially inappropriate prescribing in older residents in Irish nursing homes, Age and Ageing, vol.42, issue.1, 2013. ,
DOI : 10.1093/ageing/afs068
Proton pump inhibitors utilisation in older people in New Zealand from, Intern Med J. 2015, vol.45, issue.6, pp.624-633, 2005. ,
Italy: Pensiero Scientifico Editore, 2006. ,
Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002???2009, PLoS ONE, vol.81, issue.1, p.56060, 2002. ,
DOI : 10.1371/journal.pone.0056060.t004
Use of anti-secretory medication: a population-based cohort study, Alimentary Pharmacology and Therapeutics, vol.120, issue.5, pp.577-83, 2004. ,
DOI : 10.1046/j.1365-2036.1999.00524.x
Marked increase in proton pump inhibitors use in Australia, Pharmacoepidemiology and Drug Safety, vol.28, issue.4, pp.1019-1043, 2010. ,
DOI : 10.1002/pds.1969
Review article: the long-term use of proton-pump inhibitors, Alimentary Pharmacology and Therapeutics, vol.159, issue.5, pp.55-63, 2005. ,
DOI : 10.1080/003655201750422585
Proton pump inhibitors: potential cost reductions by applying prescribing guidelines, BMC Health Services Research, vol.11, issue.3, p.408, 2012. ,
DOI : 10.1586/erp.11.24
Long term acid suppressing treatment in general practice, BMJ, vol.308, issue.6932, pp.827-857, 1994. ,
DOI : 10.1136/bmj.308.6932.827
du nouveau dans la détection des prescriptions médicamenteuses inappropriées dans la population âgée, Rev Geriatr, vol.35, issue.5, pp.341-348, 2010. ,
Proton pump inhibitors: Are we still prescribing them without valid indications? Australas Med J, pp.465-70, 2014. ,
Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board, Geriatrics & Gerontology International, vol.29, issue.13-14, pp.1002-1011, 2013. ,
DOI : 10.1111/ggi.12047
Appropriate proton pump inhibitor use among older adults: A retrospective chart review. The American Journal of Geriatric Pharmacotherapy, 2008. ,
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, vol.373, pp.1849-1860, 2009. ,
Low-Dose Aspirin for the Prevention of Atherothrombosis, New England Journal of Medicine, vol.353, issue.22, pp.2373-83, 2005. ,
DOI : 10.1056/NEJMra052717
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation. The Lancet Neurology, pp.1066-81, 2012. ,
Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, vol.310, issue.6983, pp.827-857, 1995. ,
DOI : 10.1136/bmj.310.6983.827
Antiplatelet drugs in the elderly : prescriptions often inappropriate and reduced tolerance by associated diseases and drugs. Fund Clin Pharmacol, pp.307-320, 2012. ,
Potentially inappropriate prescribing including underuse amongst older patients with cognitive or psychiatric co-morbidities, Age Ageing, 2010. ,
Potentially inappropriate prescribing cardiovascular medications in the aged population: prospective study in a district hospital centre (France) Presse Med, Feb, vol.44, issue.2, pp.41-50, 2015. ,
Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging, pp.829-866, 2012. ,
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations, Gut, vol.55, issue.12, pp.1731-1739, 2006. ,
DOI : 10.1136/gut.2005.080754
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants, Clinical Gastroenterology and Hepatology, vol.13, issue.5, 2015. ,
DOI : 10.1016/j.cgh.2014.11.007
Vascular and upper gastrointestinal effects of non-steriodal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials, Lancet, vol.382, pp.769-79, 2013. ,
Topical NSAIDs for chronic musculoskeletal pain in adults, Cochrane Database Syst Rev, vol.9, p.7400, 2012. ,
Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs, BMJ, vol.316, issue.7128, pp.333-371, 1998. ,
DOI : 10.1136/bmj.316.7128.333
Corticothérapie systémique : les mesures d'accompagnement. La Revue de Médecine Interne, pp.279-83, 2013. ,
Intéractions médicamenteuses. Le guide 2015, 2015. ,
Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy, Journal of Internal Medicine, vol.20, issue.Suppl. 6, pp.619-651, 1994. ,
DOI : 10.1111/j.1365-2796.1994.tb00855.x
Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs, Annals of Internal Medicine, vol.114, issue.9, pp.735-775, 1991. ,
DOI : 10.7326/0003-4819-114-9-735
Epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, vol.54, issue.5, pp.710-717, 2005. ,
DOI : 10.1136/gut.2004.051821
Natural history of gastro-oesophageal reflux disease diagnosed in general practice, Alimentary Pharmacology and Therapeutics, vol.18, issue.1, pp.751-760, 2004. ,
DOI : 10.1001/jama.287.15.1972
Prevalence of gastroesophageal reflux in elderly patients in a primary care setting, Am J Gastroenterol, vol.86, issue.8, pp.965-70, 1991. ,
Reflux and Acid Peptic Diseases in the Elderly, Clinics in Geriatric Medicine, vol.30, issue.1, pp.29-41, 2014. ,
DOI : 10.1016/j.cger.2013.10.006
How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practices, J Fam Pract, vol.51, issue.3, pp.241-246, 2002. ,
Long-term prescribing of proton pump inhibitors in general practice, Br J Gen Pract, vol.49, issue.443, pp.451-454, 1999. ,
Clinical Features of Reflux Esophagitis in Older People: A Study of 840 Consecutive Patients, Journal of the American Geriatrics Society, vol.40, issue.(S, pp.1537-1579, 2006. ,
DOI : 10.1111/j.1532-5415.2006.00899.x
The diagnosis and management of hiatus hernia, BMJ, vol.349, issue.oct23 1, p.6154, 2014. ,
DOI : 10.1136/bmj.g6154
Risk factors in the aetiology of hiatus hernia, European Journal of Gastroenterology & Hepatology, vol.23, issue.2, pp.133-141, 2011. ,
DOI : 10.1097/MEG.0b013e3283426f57
Faut-il traiter toutes les maladies de la personne ??g??e ?, Th??rapie, vol.59, issue.2, pp.227-259, 2004. ,
DOI : 10.2515/therapie:2004044
Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care, International Journal of Clinical Practice, vol.16, issue.Suppl 3, pp.767-73, 2012. ,
DOI : 10.1111/j.1742-1241.2012.02973.x
Proton pump inhibitors: a survey of prescribing in an Irish general hospital, International Journal of Clinical Practice, vol.51, issue.1, pp.31-35, 2005. ,
DOI : 10.1111/j.1742-1241.2004.00298.x
Long-term use of acid suppression started inappropriately during hospitalization, Alimentary Pharmacology and Therapeutics, vol.61, issue.10, pp.1203-1212, 2005. ,
DOI : 10.1001/jama.292.16.1955
Continuation of Proton Pump Inhibitors from Hospital to Community, Pharmacy World & Science, vol.172, issue.1, pp.189-93, 2006. ,
DOI : 10.1007/s11096-006-9028-4
Four-Year Trends of Inappropriate Proton Pump Inhibitor Use After Hospital Discharge, Southern Medical Journal, vol.106, issue.4, 2013. ,
DOI : 10.1097/SMJ.0b013e31828db01f
Evaluation de la politique française des médicaments génériques, 2012. ,
Appropriateness of treatment recommendations for PPI in hospital discharge letters, European Journal of Clinical Pharmacology, vol.10, issue.Suppl 2, 2010. ,
DOI : 10.1007/s00228-010-0871-9
URL : https://hal.archives-ouvertes.fr/hal-00613749
Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors, Annals of Pharmacotherapy, vol.13, issue.1, pp.29-38 ,
DOI : 10.1371/journal.pone.0043617
Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians, JAMA, vol.297, issue.8, pp.831-872, 2007. ,
DOI : 10.1001/jama.297.8.831
Un nouvel outil pour lutter contre la iatrogénie chez les personnes âgées, Rev Geriatr, vol.39, issue.10, pp.649-57, 2014. ,
Dossier médical partagé : le retour annoncé de l'usine à gaz. [internet]. [accès le 02, Disponible sur, 2015. ,
Synthèse médicale Volet de Synthèse Médicale (VSM) élaboré à partir du modèle métier de synthèse médicale. Paris. Octobre 2013. (en ligne). (accès le 08, 2015. ,
Short report. Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents, Age and Ageing, vol.29, issue.5, pp.451-454, 2000. ,
DOI : 10.1093/ageing/29.5.451
Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes, British Journal of Clinical Pharmacology, vol.42, issue.3, pp.257-65, 2001. ,
DOI : 10.1046/j.1365-2125.2001.00347.x
Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial, Age and Ageing, vol.35, issue.6, pp.586-91, 2006. ,
DOI : 10.1093/ageing/afl075
Clinical pharmacists??? interventions in a German University Hospital, Pharmacy World & Science, vol.30, issue.2, pp.194-203, 2010. ,
DOI : 10.1007/s11096-010-9367-z
Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes, International Journal of Clinical Pharmacy, vol.51, issue.1, pp.549-57, 2011. ,
DOI : 10.1007/s11096-011-9506-1
Deprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes, Clinics in Geriatric Medicine, vol.28, issue.2, pp.237-53 ,
DOI : 10.1016/j.cger.2012.01.006
Medication Withdrawal Trials in People Aged 65 Years and Older, Drugs & Aging, vol.166, issue.12, pp.1021-1052, 2008. ,
DOI : 10.2165/0002512-200825120-00004
Strategies for discontinuation of proton pump inhibitors: a systematic review, Family Practice, vol.31, issue.6, 2014. ,
DOI : 10.1093/fampra/cmu050
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy, Gastroenterology, vol.137, issue.1, pp.80-87, 2009. ,
DOI : 10.1053/j.gastro.2009.03.058
Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment, Scandinavian Journal of Gastroenterology, vol.24, issue.5, 2013. ,
DOI : 10.1080/00365520510011579
Patient Barriers to and Enablers of Deprescribing: a Systematic Review, Drugs & Aging, vol.13, issue.10, pp.793-807, 2013. ,
DOI : 10.1007/s40266-013-0106-8
Qualitative insights into general practitioners views on polypharmacy, BMC Family Practice, vol.5, issue.3, p.65, 2010. ,
DOI : 10.1016/j.amjopharm.2007.03.004
What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process, PLOS ONE, vol.1, issue.Suppl 2, p.122246, 2015. ,
DOI : 10.1371/journal.pone.0122246.s003
Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals, JAMA, vol.297, issue.11, pp.1233-1240, 2007. ,
DOI : 10.1001/jama.297.11.1233
GUIDELINE-DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS, Journal of the American Geriatrics Society, vol.57, issue.2, 2011. ,
DOI : 10.1111/j.1532-5415.2011.03252.x
Off-label prescribing in older patients. Drugs Aging, pp.427-461, 2012. ,
Les facteurs non médicaux de la décision médicale dans le cadre de la prescription des IPP, Recherche sur le système de santé : 2005-2007. Saint-Etienne: RN3S, pp.237-83, 2008. ,
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective, Journal of Gastroenterology, vol.11, issue.1, pp.626-663 ,
DOI : 10.1007/s00535-015-1038-3
Peptic ulcer disease, The Lancet, vol.374, issue.9699, pp.1449-61, 2009. ,
DOI : 10.1016/S0140-6736(09)60938-7
Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials, The American Journal of Medicine, vol.119, issue.8, pp.624-662, 2006. ,
DOI : 10.1016/j.amjmed.2005.10.039
Guidelines for Prevention of NSAID-Related Ulcer Complications, The American Journal of Gastroenterology, vol.328, issue.3, pp.728-766, 2009. ,
DOI : 10.1038/ajg.2009.115
Which organizational characteristics are associated with increased management of depression using antidepressants in US nursing homes? Med Care, pp.992-1000, 2004. ,
Variation in Nursing Home Antipsychotic Prescribing Rates, Archives of Internal Medicine, vol.167, issue.7, pp.676-83, 2007. ,
DOI : 10.1001/archinte.167.7.676
Pharmacy interventions on prescribing in nursing homes: from evidence to practice. Ther Adv Drug Saf, pp.103-115, 2011. ,
The Effect of Interventions to Reduce Potentially Inappropriate Antibiotic Prescribing in Long-Term Care Facilities: a Systematic Review of Randomised Controlled Trials, Drugs & Aging, vol.332, issue.7538, pp.401-409 ,
DOI : 10.1007/s40266-013-0066-z
Outil Diagnostic de la prise en charge médicamenteuse en EHPAD. [internet]. [accès le 11, Disponible sur, 2015. ,
Ressource Prise en charge en secteur sécurisé Durée moyenne de présence Changement de médecin traitant à l'entrée FOGD dans l'année Recherche d'HP dans l'année Evènement(s) hémorragique(s) dans l'année Hospitalisation(s) dans l'année Prescription d'IPP : Indication Dosage Horaire de prise Molécule Durée du traitement Traitement antérieur à l'entrée en EHPAD Co-prescriptions : Anti agrégant plaquettaire Anticoagulant AINS Corticoïdes ABSTRACT Long term use of proton pump inhibitors in nursing home: documented indications and associated prescriptions for 134 residents ,